0
Review ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Marine & Wildlife Remediation Sign in to save

Environmental Fate, Ecotoxicity, and Remediation of Heterocyclic Pharmaceuticals as Emerging Contaminants: A Review of Long-Term Risks and Impacts

Organics 2025 16 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 68 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Oussama Baaloudj, Laura Scrano, Sabino Aurelio Bufo, Lee-Ann Modley, Filomena Lelario, Angelica Rebecca Zizzamia, Lucia Emanuele, Monica Brienza

Summary

This review examines heterocyclic pharmaceutical compounds, which make up over 90% of new medications, as emerging environmental contaminants. These drugs persist in the environment and can cause neurotoxicity, genetic damage, and cancer risk. While not directly about microplastics, the study highlights how persistent chemical pollutants, similar to microplastics, accumulate in the environment and pose long-term health threats.

Study Type Environmental

Heterocyclic pharmaceuticals are emerging contaminants due to their toxic, carcinogenic nature and detrimental impact on the natural ecosystem. These compounds pose a significant environmental concern given their widespread use in medical therapy, constituting over 90% of new medications. Their unique chemical structure contributes to their persistence in various environmental matrices, necessitating urgent measures to mitigate their risks. This review comprehensively examines the sources, environmental fate, toxicity, and long-term risks associated with heterocyclic pharmaceuticals, proposing potential remediation strategies. The article commences with an overview of the diverse types of heterocyclic pharmaceuticals and their applications, focusing on compounds containing heteroatoms such as nitrogen, oxygen, and sulfur. Subsequently, it explores the sources and pathways through which these pollutants enter the environment, including wastewater discharge, agricultural runoff, improper disposal, resistance to biodegradation, and bioaccumulation. The toxic effects and long-term consequences of exposure to heterocyclic pharmaceuticals are then discussed, encompassing neurotoxicity, genotoxicity, mutagenesis, cardiovascular and metabolic toxicity, carcinogenicity, and teratogenesis. Additionally, this review summarizes various remediation strategies and treatment solutions aimed at reducing the environmental impact of these compounds, drawing insights from the literature. The research concludes by identifying critical areas for future research, emphasizing the urgent need for more effective remediation strategies to address the growing concern posed by these emerging contaminants.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Environmental Fate of Emerging Organic Micro-Contaminants

This review covers the sources, fate, and toxicity of pharmaceuticals and other organic micropollutants in natural and built environments. It examines how these contaminants, which often co-occur with microplastics, persist in water systems and affect aquatic organisms.

Article Tier 2

Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems

This review examines how pharmaceutical drugs are polluting waterways worldwide because conventional wastewater treatment cannot effectively remove them. The authors focus on bioremediation approaches, especially using fungi, as a more sustainable and eco-friendly way to break down these drug residues. While not directly about microplastics, the research is relevant because microplastics can carry pharmaceutical compounds in water, and better water treatment would address both contaminants.

Article Tier 2

A review of the influences of microplastics on toxicity and transgenerational effects of pharmaceutical and personal care products in aquatic environment

This review examined how microplastics interact with pharmaceutical and personal care products in aquatic environments, including their combined toxicity and transgenerational effects. Researchers found that microplastics can adsorb these chemicals and act as carriers, and that both pollutants can accumulate in fish and aquatic invertebrates and transfer toxic effects to offspring.

Article Tier 2

Microplastic–Pharmaceuticals Interaction in Water Systems

This review examined the interactions between microplastics and pharmaceutical compounds in aquatic environments, exploring how microplastics act as vectors that concentrate, transport, and potentially enhance the bioavailability and toxicity of drug residues in water.

Systematic Review Tier 1

Micro(nano)plastics as a vector of pharmaceuticals in aquatic ecosystem: Historical review and future trends

This systematic review examines how microplastics and nanoplastics in water can absorb and carry pharmaceutical drugs, creating a combined pollution threat. When medications attach to tiny plastic particles in rivers and oceans, they may become more harmful to aquatic life and potentially to humans who consume contaminated seafood or water. The research traces how this emerging double-threat has grown since 2018 and identifies key knowledge gaps.

Share this paper